A new galenic formulation of selegiline (Xilopae) in the treatment of Parkinson 
disease

Müller, T.; Glass, J.; Müller, D.; Link, A.; Schenk, C.; Rammes, G.

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

A new galenic formulation of selegiline (Xilopae) in the treatment of Parkinson disease

MPS-Authors

/persons/resource/persons80484

Rammes, G.
Max Planck Institute of Psychiatry, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Müller, T., Glass, J., Müller, D., Link, A., Schenk, C., & Rammes, G. (2004). A new galenic formulation of selegiline (Xilopae) in the treatment of Parkinson disease. Aktuelle Neurologie, 31(7), 347-352.

Cite as: https://hdl.handle.net/11858/00-001M-0000-000E-9CAE-E

Abstract

There is no abstract available